Hidradenitis Suppurativa Foundatio… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2022

Legal Domicile

Principal Officer

BRENT HAZELETT

Phone

9193780707

Tax Period

2023-01-01 to 2023-12-31

Hidradenitis Suppurativa Foundation Inc, founded in 2022, is a community nonprofit in the Human Services sector that reported $1.1M in total revenue in fiscal year 2023. Revenue decreased 9% compared to the prior year. Expenses of $1.2M exceeded revenue, resulting in a 15% operating deficit.

Mission

THE MISSION OF THE HS FOUNDATION IS TO IMPROVE THE LIVES OF PEOPLE AFFECTED BY HS THROUGH ADVOCACY, EDUCATION AND RESEARCH.

Program Service Accomplishments

Program 1

Expenses: $251,948 Revenue: $290,000

The Eighth Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) was held October 13-15, 2023, in Phoenix, Arizona. Co-organized with the Canadian HS Foundation (CHSF), over 270 attendees from ten countries participated in the event, including 36 patients and over 40 medical students. The latest advancements in HS treatment and research were presented, including the submission of over 100 abstracts.

Program 2

Expenses: $300,501

Over $280,000 in grant funding was provided through three HSF programs. The Danby Grant provided five grants totaling over $100,000, while the Translational Grant Program provided two grants totaling $150,000. Finally, the HSF funded its first ever HS fellowship through a partnership with the Dermatology Foundation for $30,000. The grants all fund research and researchers focused on the field of HS.

Program 3

Expenses: $215,182 Revenue: $50,750

The HS Foundation held its third annual educational event for dermatology residents, called HS Academy. The purpose of the event is to educate the next generation of practicing dermatologists about the latest advancements in diagnosis, pathogenesis, epidemiology, and comorbidities, as well as medical and procedure-based treatments for Hidradenitis Suppurativa through lecture, break-out sessions, and case-based studies with renowned experts and patient faculty. The event takes place over the course of three days and all expenses for attendees, including travel, is completely covered by the Foundation.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $637,160

Program Service Revenue $414,320

Investment Income $27,263

Other Revenue $0

TOTAL REVENUE $1,078,743

Expense Breakdown

Grants Paid $300,501

Salaries & Benefits $267,602

Fundraising Expenses $23,010

Program Expenses $954,794

Other Expenses $676,973

TOTAL EXPENSES $1,245,076

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,078,743	$1,179,185	-0.1%
Expenses	$1,245,076	$1,139,182	+0.1%
Net Income	$-166,333	$40,003	-5.2%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$217,770

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ILTEFAT HAMZAVI MD	IMMEDIATE PAST PRESIDENT	1.00	Director	$0	$0	$0
JOSLYN R SCIACCA KIRBY MD	PRESIDENT	3.00	Officer Director	$0	$0	$0
HADAR LEV-TOV MD	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
MARTIN OKUN MD	SECRETARY	1.00	Officer Director	$0	$0	$0
ATHENA GIERBOLINI	DIRECTOR	1.00	Director	$0	$0	$0
JENNIFER HSIAO MD	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTOPHER SAYED MD	DIRECTOR	1.00	Director	$0	$0	$0
HALEY NAIK MD	DIRECTOR	1.00	Director	$0	$0	$0
MICHELLE LOWES MBBS PHD	DIRECTOR	1.00	Director	$0	$0	$0
AMIT GARG MD	DIRECTOR	1.00	Director	$0	$0	$0
BARRY RESNIK MD	DIRECTOR	1.00	Director	$0	$0	$0
STEPHANIE GOLDBERG MD	DIRECTOR	1.00	Director	$0	$0	$0
VIVIAN SHI MD	TREASURER	1.00	Officer Director	$0	$0	$0
STEVEN DAVELUY MD	DIRECTOR	1.00	Director	$0	$0	$0
AFSANEH ALAVI MD	DIRECTOR	1.00	Director	$0	$0	$0
DONNA ATHERTON	DIRECTOR	1.00	Director	$0	$0	$0
GINETTE OKOYE MD	DIRECTOR	1.00	Director	$0	$0	$0
BRENT HAZELETT	CHEIF EXECTIVE OFFICER	45.00	Officer	$211,000	$6,770	$217,770

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,078,743	$1,245,076	$1,268,561	$-166,333

Hidradenitis Suppurativa Foundation Inc